Esomeprazole: Clinical Trials

88 trials of Esomeprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

75 completed, 9 unknown, 3 terminated, 1 recruiting. 88 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 188Completed 75, Unknown 9, Terminated 3, Recruiting 1
Phase 26Completed 4, Unknown 2

Follow Esomeprazole: new trials by email Literature Review of Esomeprazole trials Research Report on Esomeprazole

Trials (filtered) newest first · largest first

All 88 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug Interaction Study on Linaprazan Glurate Capsules
Linaprazan Glurate Capsules, Bismuth Potassium Citrate Capsules, Amoxicillin Capsules - Healthy Volunteers, Patients
Phase 1CompletedJiangsu Sinorda Biomedicine Co., Ltd562025-09-082026-01-06
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
INCB161734, Itraconazole, Rifampin - Healthy Participants
Phase 1CompletedIncyte Corporation632025-07-162025-11-26
A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults
Zasocitinib, COC, Metformin - Healthy Volunteers
Phase 1CompletedTakeda782025-01-232025-04-04
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Ledaborbactam etzadroxil, Ceftibuten, Ceftibuten-ledaborbactam etzadroxil - Healthy Volunteer, Pharmacokinetics
Phase 1RecruitingBasilea Pharmaceutica962025-01-072026-11-05
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers
NX-5948, Esomeprazole, Placebo - Healthy Volunteer
Phase 1CompletedNurix Therapeutics, Inc.2232024-11-302026-07-28
A Phase I Study of LX22001 for Injection in Healthy Subjects
LX22001 for Injeciton, Tegoprazan tablet, Esomeprazole sodium for injection - Healthy
Phase 1CompletedShandong Luoxin Pharmaceutical Group Stock Co., Ltd.1002024-08-052026-11-19
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
Esomeprazole, Placebo - Fatty Liver Disease, Steatohepatitis, Nonalcoholic
Phase 1 / Phase 2UnknownSadat City University462024-06-012024-05-22
A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood
BI 300202, esomeprazole - Healthy
Phase 1CompletedBoehringer Ingelheim152024-05-222025-01-22
A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants
Emraclidine, Esomeprazole - Healthy Participants
Phase 1CompletedCerevel Therapeutics, LLC202024-05-102024-07-24
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
BAY2927088, Esomeprazole, Food - Advanced Non-small Cell Lung Cancer, EGFR Mutation
Phase 1CompletedBayer212024-03-292024-07-05
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant
INCB160058, Placebo, Esomeprazole - Healthy Participants
Phase 1CompletedIncyte Corporation1372024-03-142025-10-14
A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant
vepdegestrant, esomeprazole - Healthy
Phase 1CompletedPfizer122024-02-232024-06-03
A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood
Avenciguat (BI 685509) (intended commercial formulation (iCF)), Avenciguat (BI 685509) (trial formulation 2 (TF2)), esomeprazole - Healthy
Phase 1CompletedBoehringer Ingelheim162024-01-162024-03-20
Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects
Clopidogrel 75 mg, Tegoprazan 25 mg, Esomeprazole 20mg - Healthy
Phase 1UnknownHK inno.N Corporation482023-12-052023-12-11
A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B
UCB0599, Esomeprazole, Placebo - Healthy Study Participants
Phase 1CompletedUCB Biopharma SRL732023-05-312025-12-22
A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants
Brensocatib, Rifampin, Esomeprazole - Healthy Volunteers
Phase 1CompletedInsmed Incorporated322023-05-102023-08-21
Metformin and Esomeprazole For Preterm Pre-eclampsia
Esomeprazole 20mg - Preeclampsia Severe, Preeclampsia Second Trimester
Phase 1UnknownChristiana Care Health Services382023-03-012023-02-10
A Study of IBI351 in Healthy Subjects
IBI351, Esomeprazole - Healthy Subjects
Phase 1CompletedInnovent Biologics (Suzhou) Co. Ltd.242023-02-162023-10-24
Drug-drug Interaction Study of XZP-3621 Tablet
XZP-3621 tablet and itraconazole oral liquid (for Arm1), XZP-3621 tablet and Rifampicin capsules (For Arm 2), XZP-3621 tablet and esomeprazole tablet (For Arm3) - Healthy Subjects
Phase 1UnknownXuanzhu Biopharmaceutical Co., Ltd.722022-11-152022-10-19
A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood
BI 1819479, Esomeprazole - Healthy
Phase 1CompletedBoehringer Ingelheim152022-10-182023-01-26

Showing 20 of 88. Sign in to see all of them.

Conditions studied

Gastroesophageal Reflux (9)  ·  Peptic Ulcer (4)  ·  Dyspepsia (2)  ·  Achlorhydria (1)  ·  Arthritis (1)  ·  Arthritis, Juvenile (1)  ·  Asthma (1)  ·  Autism Spectrum Disorder (1)  ·  Barrett Esophagus (1)  ·  Breast Neoplasms (1)  ·  Esophagitis (1)  ·  Esophagitis, Peptic (1)  ·  Fasting (1)  ·  Gastritis (1)  ·  Gastrointestinal Diseases (1)

Sponsors

AstraZeneca (13)  ·  Takeda (6)  ·  HK inno.N Corporation (4)  ·  Boehringer Ingelheim (3)  ·  Millennium Pharmaceuticals, Inc. (3)  ·  Pfizer (3)  ·  Torrent Pharmaceuticals Limited (3)  ·  Yuhan Corporation (3)  ·  Bayer (2)  ·  Eli Lilly and Company (2)  ·  Hoffmann-La Roche (2)  ·  Incyte Corporation (2)  ·  Seoul National University Hospital (2)  ·  Yooyoung Pharmaceutical Co., Ltd. (2)  ·  Addpharma Inc. (1)

Countries

United States (37)  ·  South Korea (17)  ·  China (6)  ·  Canada (5)  ·  Germany (3)  ·  Japan (3)  ·  Australia (2)  ·  Belgium (2)  ·  Egypt (2)  ·  Netherlands (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Finland (1)  ·  Hungary (1)  ·  Spain (1)

Top investigators

Lynne Durborow (2)  ·  SeungHwan Lee, MD, PhD (2)  ·  Tore Lind (2)  ·  Ahmed Elshafeey, Ph.D. Pharma (1)  ·  Aziz Laurent, MD (1)  ·  Bo Fransson (1)  ·  Choon Ok Kim, MD (1)  ·  Christopher Billings ., D.O (1)

Results publications

PMID 27875488, PMID 21171670, PMID 22464259, PMID 22631032, PMID 22832034, PMID 23333143, PMID 24677117, PMID 28052855, PMID 30445008, PMID 31564831, PMID 32274381, PMID 33062627, PMID 34621707, PMID 34825782, PMID 35218604, PMID 35281316, PMID 36409435, PMID 36897544, PMID 39803609, PMID 41120363, PMID 41348226, PMID 41920422

NIH funding

2023 (2), 2014 (1), 2017 (1)